Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP

(UNH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

UnitedHealth Group : Increase of volatility

share with twitter share with LinkedIn share with facebook
share via e-mail
06/11/2019 | 03:56am EDT
long trade under condition
Expirée le 06/21/2019
Entry price : 253$ | Target : 272$ | Stop-loss : 245$ | Cancellation Level : 237$ | Potential : 7.51%
UnitedHealth Group shares have recently experienced an upward movement with a return of higher volumes and volatility. This technical chart pattern suggests a continuation of the upward movement.
Investors should benefit from the breakout of the $ 253 level to target the $ 272.
Chart UNITEDHEALTH GROUP
Duration : Period :
UnitedHealth Group Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.

Strengths
  • Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 248.78.
  • Below the resistance at 248.78 USD, the stock shows a negative configuration when looking looking at the weekly chart.
UnitedHealth Group : Increase of volatility
Stocks mentioned in the article
ChangeLast1st jan.
THOMSON REUTERS CORP -0.97% 88.7 Delayed Quote.35.86%
UNITEDHEALTH GROUP 0.02% 232.89 Delayed Quote.-6.53%

Patrick Rejaunier
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2019 242 B
EBIT 2019 19 408 M
Net income 2019 13 635 M
Debt 2019 26 015 M
Yield 2019 1,78%
P/E ratio 2019 16,5x
P/E ratio 2020 14,6x
EV / Sales2019 1,02x
EV / Sales2020 0,93x
Capitalization 221 B
Upcoming event on UNITEDHEALTH GROUP
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 292,96  $
Last Close Price 232,89  $
Spread / Highest target 41,7%
Spread / Average Target 25,8%
Spread / Lowest Target 5,20%
EPS Revisions
Managers
NameTitle
David Scott Wichmann Chief Executive Officer & Director
Stephen J. Hemsley Executive Chairman
John Franklin Rex Chief Financial Officer
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Richard T. Burke Non-Executive Chairman
Sector and Competitors
1st jan.Capitalization (M$)
UNITEDHEALTH GROUP-6.53%220 705
ANTHEM INC-4.01%64 489
CIGNA CORP-15.03%60 939
HUMANA-3.21%37 458
CENTENE CORPORATION-19.53%19 187
WELLCARE HEALTH PLANS14.32%13 579